Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
1.780
-0.010 (-0.56%)
At close: Mar 28, 2024, 4:00 PM
1.781
+0.001 (0.06%)
After-hours: Mar 28, 2024, 4:15 PM EDT

Corvus Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Cash & Equivalents
12.6213.1663.4616.465.1539.245.115.054.1112.52
Short-Term Investments
14.5329.145.9927.872.8375.444.95129.8590.280
Cash & Cash Equivalents
27.1542.369.4544.2677.98114.690.06134.994.3912.52
Cash Growth
-35.82%-39.09%56.92%-43.24%-31.95%27.25%-33.24%42.92%654.06%-
Receivables
0.030.590.510000000
Other Current Assets
0.780.771.351.081.360.991.181.141.280.01
Total Current Assets
27.9643.6671.3145.3479.34115.5991.23136.0395.6612.53
Property, Plant & Equipment
1.392.573.642.553.792.182.673.251.850
Long-Term Investments
16.1221.8834.2737.23000000
Other Long-Term Assets
0.090.130.240.410.510.460.870.870.950
Total Long-Term Assets
17.624.5838.1440.194.32.643.544.122.80
Total Assets
45.5568.24109.4685.5383.65118.2394.78140.1598.4612.53
Accounts Payable
1.531.981.573.472.4523.451.91.580.06
Current Debt
1.371.231.051.080.8800000
Other Current Liabilities
3.977.557.087.66.95.035.524.041.52.62
Total Current Liabilities
6.8710.759.6912.1510.237.038.975.943.072.67
Long-Term Debt
01.372.61.232.3100000
Other Long-Term Liabilities
000000.870.971.410.710
Total Long-Term Liabilities
01.372.61.232.310.870.971.410.710
Total Liabilities
6.8712.1312.2913.3812.547.99.947.353.782.68
Total Debt
1.372.63.652.313.1900000
Debt Growth
-47.17%-28.68%57.88%-27.54%------
Retained Earnings
-334.72-307.69-266.38-223.14-217.15-170.47-123.53-67.87-31.5-0.16
Comprehensive Income
-0.97-0.561.8700.03-0.03-0.04-0.04-0.050
Shareholders' Equity
38.6856.1297.1672.1571.11110.3484.84132.8-31.1-0.16
Net Cash / Debt
25.7839.765.841.9574.79114.690.06134.994.3912.52
Net Cash / Debt Growth
-35.08%-39.67%56.87%-43.91%-34.73%27.25%-33.24%42.92%654.06%-
Net Cash Per Share
0.540.851.571.422.554.174.408.75252.6173.51
Working Capital
21.0932.9161.6233.1969.12108.5682.27130.0992.599.86
Book Value Per Share
0.811.212.322.452.424.014.148.61-83.24-0.93
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).